Valuation (47%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -60.45 | 33.52 |
PEG Ratio (TTM) | -1.80 | 10.17 |
P/S Ratio (TTM) | 1.47 | 4.49 |
P/B Ratio (TTM) | 1.84 | 6.41 |
P/FCF Ratio (TTM) | 76.82 | 28.53 |
Price to 5YR AVG Earnings Ratio | 34.10 | 46.93 |
Price to 5YR AVG FCF Ratio | 19.85 | 53.47 |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | -1.29% | 8.51% |
ROE (TTM) | -3.02% | 20.60% |
Net Profit Margin (TTM) | -2.46% | 12.03% |
ROIC 5YR AVG | 7.05% | 20.58% |
Growth (15%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -584.91% | -1.86% | -14.62% |
Revenue | 2.24% | -4.32% | 0.47% |
Net Income | -587.29% | -2.37% | -14.99% |
Cash Flow | 260.50% | -10.22% | -7.37% |
Health (44%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.28 | 1.62 |
Quick Ratio (TTM) | 1.35 | 1.09 |
D/E Ratio (TTM) | 0.88 | 0.69 |
Interest Coverage (TTM) | 1.78 | 16.53 |
Piotroski F-Score | 4 | 7 |
Altman Z-Score | 1.64 | 5.37 |
LTL to 5YR AVG FCF | 10.66 | 7.40 |
Shares Outstanding Growth 5YR AVG | -0.48% | 0.61% |